Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-29 @ 6:48 AM
Study NCT ID:
NCT06293651
Status:
RECRUITING
Last Update Posted:
2025-02-12
First Post:
2024-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor:
Dong-A ST Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-10
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-15
First Submit QC Date:
None
Study First Post Date:
2024-03-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-10
Last Update Post Date:
2025-02-12
Last Update Post Date Type:
ACTUAL